Siemens Healthineers AG (OTCMKTS:SMMNY) Short Interest Up 143.6% in July

Siemens Healthineers AG (OTCMKTS:SMMNY) saw a large increase in short interest in July. As of July 15th, there was short interest totaling 125,563 shares, an increase of 143.6% from the June 30th total of 51,538 shares. Based on an average daily trading volume, of 209,024 shares, the days-to-cover ratio is currently 0.6 days.

Analysts Set New Price Targets

Separately, Zacks Research downgraded shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a report on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy”.

Siemens Healthineers Stock Performance

SMMNY stock opened at $20.46 on Wednesday. Siemens Healthineers has a 1-year low of $19.20 and a 1-year high of $28.92. The business has a 50 day simple moving average of $19.88 and a two-hundred day simple moving average of $21.90.

Siemens Healthineers (OTCMKTS:SMMNY) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.02. The company had revenue of $6.68 billion for the quarter, compared to the consensus estimate of $6.96 billion.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.